Shares of Pulmonx Co. (NASDAQ:LUNG – Get Free Report) have been assigned an average rating of “Moderate Buy” from the six ...

REDWOOD CITY, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced ...

Pulmonx Corporation (LUNG) has disclosed a new risk, in the Share Price & Shareholder Rights category. Pulmonx Corporation ...

5.7% of Pulmonx shares are owned by company insiders. Comparatively, 10.1% of Biotricity shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds ...

Pulmonx Corporation (LUNG) closed the last trading session at $6.20, gaining 1.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by ...

Try Now>> See the top stocks recommended by analysts >> Read More on LUNG: Pulmonx Corporation Registered Shs NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, and the American Lung ...

Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for ...